Medicare Enrolled

Dr. Amos Katz, MD

Neurology · Eatontown, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
135 HIGHWAY 35, Eatontown, NJ 07724
7327983620
In practice since 2006 (19 years)
NPI: 1952411340 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Katz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Katz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Katz

Dr. Amos Katz is a neurology specialist in Eatontown, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Katz performed 222 Medicare services across 138 unique beneficiaries.

Between the years covered by Open Payments, Dr. Katz received a total of $746,226 from 39 pharmaceutical and/or device companies across 1793 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Katz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 222 Medicare services $746,226 industry payments

Medicare Practice Summary

Medicare Utilization ↗
222
Medicare services
Bottom 20% in NJ for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
138
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~12 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 222 $72 $258
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$746,226
Total received (2018-2024)
Avg $106,604/year across 7 years
Top 1% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
1,793
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$689,079 (92.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$49,629 (6.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,518 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$50,051
2023
$54,475
2022
$102,100
2021
$91,964
2020
$72,736
2019
$140,750
2018
$234,150

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
TG Therapeutics, Inc.
$18,095
E.R. Squibb & Sons, L.L.C.
$14,587
Biogen, Inc.
$11,715
Celgene Corporation
$3,680
ABBVIE INC.
$463
Genentech USA, Inc.
$386
EMD Serono, Inc.
$366
Novartis Pharmaceuticals Corporation
$271
Otsuka America Pharmaceutical, Inc.
$139
GENZYME CORPORATION
$53
Lundbeck LLC
$52
Mallinckrodt Hospital Products Inc.
$51
ANI Pharmaceuticals, Inc.
$47
Amgen Inc.
$46
Alexion Pharmaceuticals, Inc.
$37
PFIZER INC.
$35
Merz Pharmaceuticals, LLC
$17
Cycle Pharmaceuticals Inc
$12
Top 3 companies account for 88.7% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$170,076
Biogen, Inc.
$160,021
Genentech USA, Inc.
$91,903
E.R. Squibb & Sons, L.L.C.
$77,780
Novartis Pharmaceuticals Corporation
$66,990
Celgene Corporation
$30,400
TG THERAPEUTICS, INC.
$27,150
Allergan Inc.
$19,942
Teva Pharmaceuticals USA, Inc.
$19,311
TG Therapeutics, Inc.
$18,095
EMD Serono, Inc.
$17,038
Janssen Pharmaceuticals, Inc
$13,502
Allergan, Inc.
$9,167
ABBVIE INC.
$6,501
Alexion Pharmaceuticals, Inc.
$4,618
Horizon Therapeutics plc
$4,564
Acorda Therapeutics, Inc
$4,519
Mallinckrodt LLC
$2,091
Banner Life Sciences, LLC
$817
Avanir Pharmaceuticals, Inc.
$440
Ipsen Biopharmaceuticals, Inc
$172
Otsuka America Pharmaceutical, Inc.
$153
Mallinckrodt Hospital Products Inc.
$147
Biohaven Pharmaceuticals, Inc.
$132
Lundbeck LLC
$132
Amgen Inc.
$104
Mallinckrodt Enterprises LLC
$82
Biohaven Pharmaceutical Holding Company Ltd.
$57
AbbVie Inc.
$55
PFIZER INC.
$52
ANI Pharmaceuticals, Inc.
$47
Bayer HealthCare Pharmaceuticals Inc.
$42
Merz Pharmaceuticals, LLC
$31
Medtronic, Inc.
$23
Medtronic USA, Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$17
SANOFI-AVENTIS U.S. LLC
$12
Cycle Pharmaceuticals Inc
$12
AbbVie, Inc.
$11
Top 3 companies account for 56.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AUBAGIO · AVONEX · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Bafiertam · Betaseron · COMIRNATY · COPAXONE · DISEASE STATE · DYSPORT · Dysport · Enspryng · GILENYA · INBRIJA · INTELLIS ADAPTIVESTIM · KESIMPTA · LEMTRADA · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NUEDEXTA · NURTEC ODT · Nuedexta · OCREVUS · Ocrevus · Ozanimod · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · Rebif · SOLIRIS · SYNCHROMED · Soliris · TECFIDERA · TYSABRI · Tascenso ODT · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · Xeomin · ZEPOSIA · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in NJ.

Looking for a neurology specialist in Eatontown?
Compare neurologists in the Eatontown area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
199
Per 100K population
30.9
County median income
$122,727
Nearest hospital
RIVERVIEW MEDICAL CENTER
4.3 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Katz is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Katz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Katz performed 222 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Katz receive payments from pharmaceutical companies?
Yes. Dr. Katz received a total of $746,226 from 39 companies across 1,793 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Katz's costs compare to other neurologists in Eatontown?
Dr. Katz's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Katz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Eatontown
Browse neurologists in Eatontown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →